Long-term survival after dose-dense high-dose chemotherapy with progenitor cell support as primary treatment for patients with advanced ovarian cancer

被引:0
|
作者
Eisenhauer, E. L. [1 ]
Tew, W. P. [1 ]
Sabbatini, P. J. [1 ]
Spriggs, D. R. [1 ]
Chi, D. S. [1 ]
Barakat, R. R. [1 ]
Aghajanian, C. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
90
引用
收藏
页码:S41 / S42
页数:2
相关论文
共 50 条
  • [31] HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL STEM-CELL SUPPORT IN ADVANCED OVARIAN-CANCER
    BENEDETTIPANICI, P
    GREGGI, S
    SCAMBIA, G
    SALERNO, MG
    MENICHELLA, G
    PIERELLI, L
    FODDAI, ML
    BIZZI, B
    MANCUSO, S
    ANNALS OF MEDICINE, 1995, 27 (01) : 133 - 138
  • [32] Protein expression profiling in high-risk breast cancer patients treated with high-dose or conventional dose-dense chemotherapy
    Diallo-Danebrock, Raihanatou
    Ting, Evelyn
    Gluz, Oleg
    Herr, Alexander
    Mohrmann, Svjetlana
    Geddert, Helene
    Rody, Achim
    Schaefer, Karl-Ludwig
    Baldus, Stephan E.
    Hartmann, Arndt
    Wild, Peter J.
    Burson, Michael
    Gabbert, Helmut E.
    Nitz, Ulrike
    Poremba, Christopher
    CLINICAL CANCER RESEARCH, 2007, 13 (02) : 488 - 497
  • [33] High-dose chemotherapy and autologous stem cell transplantation in metastatic and locally advanced breast cancer: a retrospective analysis of long-term survival
    Lacaze, JL
    Fleury, J
    Choufi, B
    Kwiatkowski, F
    Cure, H
    Durando, X
    Ferriere, JP
    Moreau, L
    Mourret, MA
    Van Praagh, I
    Chollet, P
    Bay, JO
    BONE MARROW TRANSPLANTATION, 2005, 35 : S51 - S51
  • [34] High-dose chemotherapy with peripheral blood stem cell transplantation for patients with advanced ovarian cancer
    Bojko, P
    Scheulen, ME
    Hilger, R
    Oberhoff, C
    Schindler, AD
    Seeber, S
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (04) : 243 - 250
  • [35] High-dose chemotherapy with peripheral blood stem cell transplantation for patients with advanced ovarian cancer
    Peter Bojko
    Max Ernst Scheulen
    Ralf Hilger
    Carsten Oberhoff
    Adolf Eduard Schindler
    Siegfried Seeber
    Journal of Cancer Research and Clinical Oncology, 2001, 127 : 243 - 250
  • [36] Efficacy of dose-dense chemotherapy as first-line treatment of advanced ovarian cancer patients after non-optimal debulking.
    Rumyantsev, Alexey
    Tyulyandina, Alexandra
    Pokataev, Ilya
    Morkhov, Konstantin
    Nechuskina, Valentina Mikhailovna
    Tjulandin, Sergei
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] Long-term survival and toxicity of tandem high-dose therapy with high-dose melphalan and ice regimen (ifosfamide, carboplatin and etoposide) followed by autologous stem cell support in patients with advanced breast cancer
    De Rosa, L
    Anghel, G
    Pescador, L
    Blandino, F
    Lalle, M
    Pandolfi, A
    Majolino, I
    BONE MARROW TRANSPLANTATION, 2004, 33 : S167 - S167
  • [38] Long-term overall survival and event free survival after high-dose chemotherapy and stem cell support in poorprognosis Ewing's sarcoma of childhood
    Prete, A
    Rondelli, R
    Dallorso, S
    Messina, C
    Pession, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S52 - S52
  • [39] HIGH-DOSE CEF (CYCLOPHOSPHAMIDE, EPIRUBICIN, FLUOROURACIL) AS PRIMARY CHEMOTHERAPY IN LOCALLY ADVANCED BREAST CANCER: LONG TERM SURVIVAL DATA
    Conti, F.
    Perri, P.
    Sperduti, I.
    Amodio, A.
    Carpano, S.
    Foggi, P.
    Anza, M.
    Della Giulia, M.
    Lopez, M.
    EJC SUPPLEMENTS, 2008, 6 (14): : 115 - 115
  • [40] Long-term results of salvage high-dose chemotherapy for patients with germ cell tumor
    De Giorgi, U.
    Papiani, G.
    Salvioni, R.
    Marangolo, M.
    Rosti, G.
    ANNALS OF ONCOLOGY, 2005, 16 : 153 - 153